Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAUSLaGUdB0e2gxapgn718asf6CWy-adOgk3BJ_gXXIuQ#provenance>. }
Showing items 1 to 14 of
14
with 100 items per page.
- _5 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- _3 title "Recuration of TZD simulation" provenance.
- _3 type "Other" provenance.
- _3 identifier "Recuration of TZD simulation" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _5 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _4 provenance.
- assertion hadPrimarySource _3 provenance.
- _4 wasQuotedFrom _3 provenance.
- _4 value "Troglitazone treatment increased expression of two cyclin-dependent kinase inhibitors, p21(WAF1/CIP1) and p16(INK4), and reduced cyclin D1 expression, consistent with G1 arrest. is translated to Activation of CDKN2A (Homo sapiens) Gene Expression by Troglitazone" provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.